Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: A retrospective analysis of 700 patients

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 11, 1997, Pages 3553-3562

  Loh, Keh Chuan ^a,b   Greenspan, Francis S ^a   Gee, Lauren ^a   Miller, Theodore R ^a   Yeo, Peter P B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHILD; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY;

EID: 0030726290     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.82.11.4373     Document Type: Article

References (33)

1. Byar DP, Green SB, Dor P, et al. 1979 A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group. Eur J Cancer. 15:1033-1041.
2. Hay ID, Grant CS, Taylor WF, McConahey WM. 1987 Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery. 102:1088-1095.
3. Cady B, Rossi R. 1988 An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery. 104:947-953.
4. DeGroot LJ, Kaplan EL, McCormick M, Straus FH. 1990 Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab. 71:414-424.
5. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS. 1993 Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery. 114:1050-1058.
6. Mazzaferri EL, Jhiang SM. 1994 Long-term impact of initial surgical, and medical therapy on papillary and follicular thyroid cancer. Am J Med. 97:418-428.
7. Shaha AR, Loree TR, Shah JP. 1995 Prognostic factors and risk group analysis in follicular carcinoma of the thyroid. Surgery. 118:1131-1138.
8. Shaha AR, Shah JP, Loree TR. 1996 Risk group stratification and prognostic factors in papillary carcinoma of thyroid. Ann Surg Oncol. 3:534-538.
9. Hermanek P, Sobin LH, eds. 1987 UICC: TNM classification of malignant tumors, 4th ed. Berlin: Springer-Verlag.
10. Beahrs OH, Henson DE, Hutter RVP, Myers M, eds. 1988 American Joint Commision on Cancer: mauual for staging of cancer, 3rd ed. Philadelphia: Lippincott
11. Kukkonen ST, Haapiainen RK, Franssila KO, Sivula AH. 1990 Papillary thyroid carcinoma: the new, age-related TNM classification system in a retrospective analysis of 199 patients. World J Surg. 14:837-842.
12. Salvesen H, Njolstad PR, Akslen LA, Albrektsen G, Soreide O, Varhaug JE. 1992 Papillary thyroid carcinoma: a multivariate analysis of prognostic factors including an evaluation of the p-TNM staging system. Eur J Surg. 158:583-589.
13. Hay ID. 1990 Papillary thyroid carcinoma. Endocrinol Metab Clin North Am. 19:545-576.
14. Headinger CHR, ed. 1988 WHO: International histological classification of tumors. Berlin: Springer-Verlag.
15. Cox DR. 1972 Regression models and life tables. J R Stat Soc. 34:187-220.
16. Kaplan EL, Meier P. 1958 Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:457-481.
17. Segal K, Friedental R, Lubin E, Shvero J, Sulkes J, Feinmesser R. 1995 Papillary carcinoma of the thyroid. Otolaryngol Head Neck Surg. 113:356-363.
18. Gagel RF, Goepfert H, Callender DL. 1996 Changing concepts in the pathogenesis and management of thyroid carcinoma. Cancer J Clin. 46:261-283.
19. Mazzaferri EL, Young RL. 1981 Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am J Med. 70:511-518.
20. Segal K, Raveh E, Lubin E, Abraham A, Shvero J, Feinmesser R. 1996 Well-differentiated thyroid carcinoma. Am J Otolaryngol. 17:401-406.
21. Cady B, Sedgwick CE, Meissner WA, Brokwatter JR, Romagosa V, Werber J. 1976 Changing clinical pathologic, therapeutic, and survival patterns in differentiated thyroid carcinoma. Ann Surg. 184:541-553.
22. Hughes CJ, Shaha AR, Shah JP, Loree TR. 1996 Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis. Head Neck. 18:127-132.
23. Simpson WJ, McKinney SE, Carruthers JS, Gospodarowicz MK, Sutcliffe SB, Panzarella T. 1987 Papillary and follicular thyroid cancer: prognostic factors in 1,578 patients. Am J Med. 83:479-488.
24. Clark OH. 1996 Predictors of thyroid tumor aggressiveness. West J Med. 165:131-138.
25. Gilliland FD, Hunt WC, Morris DM, Key CR. 1997 Prognostic factors for thyroid carcinoma. A population-based study of 15:698 cases from the surveillance, epidemiology and end results (SEER) program 1973-1991. Cancer. 79:564-573.
26. Tezelman S, Clark OH. 1995 Current management of thyroid cancer. Adv Surg. 28:191-221.
27. Franssila KO. 1973 Is the differentiation between papillary and follicular thyroid carcinoma valid? Cancer. 32:853-864.
28. Ontai S, Straehley CJ. 1985 The surgical treatment of well-differentiated carcinoma of the thyroid. Am Surgeon. 51:653-657.
29. DeGroot LJ, Kaplan EL, Straus FH, Shukla MS. 1994 Does the method of management of papillary thyroid carcinoma make a difference in outcome? World J Surg. 18:123-130,
30. Mazzaferri EL. 1987 Papillary thyroid carcinoma: factors influencing prognosis and current therapy. Semin Oncol. 14:315-332.
31. Grebe SK, Hay ID. 1996 Thyroid cancer nodal metastases: biologic significance and therapeutic considerations. Surg Oncol Clin North Am. 5:43-63.
32. Simpson WJ, Panzarella T, Carruthers JS, Gospodarowicz MK, Sutcliffe SB. 1988 Papillary and follicular thyroid cancer: impact of treatment in 1578 patients. Int J Radiat Oncol Biol Physiol. 14:1063-1075.
33. Singer PA, Cooper DS, Daniels GH, et al. 1996 Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. Arch Intern Med. 156:2165-2172.